Anti-rheumatic drug interactions.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D000863:Antacids / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000925:Anticoagulants / Q000494:pharmacology; D002927:Cimetidine / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004338:Drug Combinations; D004347:Drug Interactions; D005938:Glucocorticoids / Q000494:pharmacology; D006046:Gold / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D010396:Penicillamine / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000863:Antacids; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D004232:Diuretics; D004338:Drug Combinations; D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D014665:Vasodilator Agents; D000493:Allopurinol; D006046:Gold; D002927:Cimetidine; D010396:Penicillamine; D011339:Probenecid; D013442:Sulfinpyrazone